Industry Overview

Germany oncology information system market was valued at $199.6 million in 2025 and is projected to reach $424.6 million by 2035, expanding at a CAGR of 7.9% from 2026 to 2035. The market comprises advanced digital platforms and software solutions that streamline oncology workflows, manage patient information, support treatment planning, and track clinical outcomes. These systems are increasingly vital in modern cancer care, as they enhance coordination among healthcare providers, improve diagnostic precision, and enable personalized treatment approaches. The rising prevalence of cancer, along with Germany’s well-established healthcare infrastructure, is significantly driving the adoption of oncology information systems across hospitals and specialized cancer treatment centers. Furthermore, the growing emphasis on integrating electronic health records (EHR) and achieving seamless interoperability between healthcare systems is accelerating the demand for these solutions, enabling more efficient data exchange and improved patient management.

Ongoing technological innovations and strategic collaborations are playing a crucial role in strengthening market growth. In April 2026, Oracle Health achieved CMS Aligned Network status and introduced a digital patient check-in solution that integrates identity verification with seamless data exchange within EHR workflows. This advancement enhances secure and interoperable data sharing while reducing administrative inefficiencies by minimizing manual processes. Similarly, in September 2024, Siemens Healthineers, through its subsidiary Varian Medical Systems, entered a 10-year collaboration with Ballad Health to deploy advanced oncology technologies, including ARIA CORE oncology management systems. This initiative aims to build an integrated digital oncology ecosystem that improves treatment workflows and supports informed clinical decision-making. Such developments underscore the increasing shift toward AI-enabled and cloud-based oncology solutions, driving more efficient, data-driven, and coordinated cancer care delivery across Germany.

Market Dynamics

AI-Powered Oncology Software Revolutionizing Cancer Care Efficiency

Software segment leads the Germany oncology information system market due to its vital role in managing patient data, treatment workflows, and clinical decision support. These platforms enable seamless integration of imaging, diagnostics, and therapy planning, significantly improving operational efficiency across healthcare facilities. In September 2025, GE HealthCare introduced its AI-supported Intelligent Radiation Therapy (iRT) solution at the ASTRO 2025 to streamline radiation oncology workflows and accelerate treatment timelines. The system enhances connectivity and reduces treatment planning time from days to minutes, enabling faster clinical decisions. Such advancements are driving widespread adoption of advanced oncology software across hospitals and cancer treatment centers.

AI-Driven Radiation Oncology Systems Redefining Precision Cancer Care

Radiation oncology continues to emerge as a critical application segment, driven by the need for precise treatment planning and seamless data integration across care pathways. Oncology information systems play a vital role in optimizing radiation therapy workflows and ensuring accurate dose delivery for improved patient outcomes. In February 2025, Elekta AB announced that its Elekta ONE Oncology Information System secured the #1 position in the 2025 Best in KLAS report for oncology (radiation). The recognition, based on extensive healthcare provider feedback, underscores its excellence in workflow management, interoperability, and clinical efficiency. Such advancements are accelerating the adoption of integrated digital oncology platforms and strengthening precision-driven cancer treatment.

Market Segmentation

• Based on product type, the market is segmented into software and services.
• Based on application, the market is segmented into medical oncology, radiation oncology, and surgical oncology.
• Based on end-user, the market is segmented into hospitals, cancer treatment centers, and research & academic institutes.

Cloud-Enabled Digital Pathology Transforming Hospital-Based Oncology Care

Hospitals continue to lead the end-user segment due to their advanced infrastructure and high patient volumes, requiring robust oncology information systems for managing complex cancer cases and ensuring coordinated care. In March 2026, Philips Healthcare expanded its digital pathology portfolio with the cloud-enabled IntelliSite Pathology Solution on HealthSuite, powered by Amazon Web Services, to enhance diagnostic efficiency and workflow scalability. The platform enables secure storage, management, and analysis of high-resolution pathology data while supporting remote collaboration and AI integration. This innovation significantly strengthens interoperability across hospital systems and improves clinical decision-making. As a result, hospitals are increasingly leveraging data-driven insights to enhance collaboration among healthcare professionals and improve patient outcomes.

Market Players Outlook

The major companies operating in the Germany oncology information system market include McKesson Corporation, Siemens Healthineers, GE HealthCare, Philips Healthcare, and Oracle Health, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their businesses and develop innovative products, maintaining their market positioning.

Recent Development

• In 2026, Coreline Soft launched an AI-powered operational infrastructure aligned with Germany’s national lung cancer screening reimbursement framework, where AI-assisted analysis became mandatory for reimbursement.

• In October 2025, SOPHiA GENETICS launched AI-powered digital twins at the ESMO Congress in Berlin to create virtual patient simulations to help oncologists forecast treatment responses and disease trajectories.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Key companies operating in the Germany oncology information system market.
• Based on the availability of data, information related to new protections and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.